Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Randomized Evaluation of Vascular Entry Site and Radiation Exposure: REVERE Trial (REVERE)

This study has been completed.
Information provided by (Responsible Party):
Total Cardiovascular Solutions Identifier:
First received: August 23, 2012
Last updated: March 11, 2016
Last verified: March 2016
The study compares radiation exposure parameters between coronary angiography procedures performed by left wrist, right wrist or groin (femoral) procedure access site

Exposure to Ionizing Radiation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Randomized Evaluation of Vascular Entry Site and Radiation Exposure: REVERE Trial.

Resource links provided by NLM:

Further study details as provided by Total Cardiovascular Solutions:

Primary Outcome Measures:
  • Air Kerma [ Time Frame: 1 day ]
    The investigators will measure Air Kerma (cumulative) at the end of the procedure of coronary angiography.

Other Outcome Measures:
  • Operator radiation exposure [ Time Frame: 1 day ]
    operator radiation exposure will be measured by a personal dosimeter worn by the operator outside the lead apron on the vest pocket.

Enrollment: 1500
Study Start Date: February 2011
Study Completion Date: August 2014
Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)
Coronary angiography procedures performed using transfemoral access
Left radial access
Coronary angiography procedures performed using left radial access site.
Right radial Access
Coronary angiography procedures performed using Right radial access site.

Detailed Description:
Patients referred for coronary angiography will be randomized to either left radial, right radial or femoral arterial access sites, and the coronary angiogram will be performed in a standard fashion, including left ventriculography. Radiation exposure parameters including Air Kerma, Dose-area product, Fluoroscopy time and Operator radiation exposure will be recorded. Operator experience as well as demographic data will be recorded.

Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients referred for diagnostic coronary angiography

Inclusion Criteria:

  • All patients undergoing diagnostic coronary angiography

Exclusion Criteria:

  • non-availability of one or more of the three access sites History of coronary artery bypass graft surgery Need for percutaneous coronary intervention.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01677481

V.S. General Hospital
Ahmedabad, Gujarat, India, 380006
Sponsors and Collaborators
Total Cardiovascular Solutions
Principal Investigator: Tejas M Patel, MD, DM Chief
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Total Cardiovascular Solutions Identifier: NCT01677481     History of Changes
Other Study ID Numbers: MIL/IMRC/RP/TP/10/2010
Study First Received: August 23, 2012
Last Updated: March 11, 2016
Individual Participant Data  
Plan to Share IPD: No processed this record on May 25, 2017